Newsroom

Press Releases

Saniona Icon blue
March 17, 2021
Financial highlights Jan - Dec 2020 (Jan - Dec 2019 restated) Revenue was SEK 8.2 M (7.2 M) Operating loss was SEK -159.4 (-93.6 M) Net loss was SEK -73.4 M (-68.8 M) Earnings per share were SEK -1.79 (-2.67) Diluted earnings per share were SEK -1.75 (-2.67) Q4 2020 (Q4 2019 restated) Revenue was
January 7, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that Rami Levin, President and Chief Executive Officer of Saniona, will present in the following three upcoming virtual investor conferences: 10th Annual LifeSci Partners Corporate Access
Displaying 11 - 20 of 20